Skip to content
Altius – Lifestyle
Author:
Immuneering Corporation
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
June 1, 2026
Anura Publishes New Guide to Help Marketers Understand Invalid Traffic
May 26, 2026
←
Previous Page
1
2
3